newsfilter
← Latest News
Business Wire·

Cybin Initiates At-The-Market Equity Program of up to US$100 Million

Cybin Inc. (NYSE:CYBN) (Cboe Canada CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and innovative next-generation